文献速递神经肿瘤

美国髓母细胞瘤患儿临床神经心理服务的人口学、医学及社区障碍

Demographic, medical, and neighborhood barriers to clinical neuropsychological services in pediatric medulloblastoma patients treated in the United States.
PubMed 文献 · J Neurooncol · 2025-01-28

该回顾性病历回顾纳入2005至2024年确诊的67例儿童髓母细胞瘤患者,仅36例(53.73%)完成临床神经心理评估;完成评估者更可能为非西班牙裔、确诊年龄更小、接受光子放疗、居住地离医院更近且社区健康资源更丰富,两组医学/临床因素无差异。

要点

  • 67例髓母细胞瘤患儿中仅36例(53.73%)完成临床神经心理评估。
  • 完成评估者更可能为非西班牙裔、确诊年龄更小、接受光子放疗。
  • 完成评估者居住地离医院更近且社区健康资源更丰富。

核心结论

  • 尽管神经心理评估被推荐为髓母细胞瘤治疗后的标准照护,但存在人口学、医学及社区层面的障碍。

研究设计与样本

  • 回顾性病历回顾,纳入2005年至2024年确诊的儿童髓母细胞瘤患者,共识别67例。

主要发现

  • 67例患者中仅36例(53.73%)完成临床神经心理评估。
  • 完成评估者更可能为非西班牙裔(X2(1,62)=9.20,p<.01)。
  • 完成评估者确诊年龄更小(t(60)=-8.40,p<0.001)。
  • 完成评估者更可能接受光子放疗(X2(1,62)=15.24,p<0.001)。
  • 完成评估者居住地离医院更近(t(60)=3.19,p=0.001)且社区健康资源更丰富(t(60)=-2.09,p=0.02);两组医学/临床因素无差异。

临床怎么用

  • 神经心理评估可评估癌症治疗后的认知变化、澄清其他诊断可能(如学习或注意力困难),并促进获得适当便利及学校和社区服务。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medulloblastoma is the most commonly occurring malignant brain tumor of childhood. Treatment includes a combination of surgery, radiation therapy, and chemotherapy, all of which are associated with cognitive impairments. Despite appreciation of the value of neuropsychological evaluations to assess for cognitive impairments, there are barriers to these evaluations. This study aimed to identify potential demographic, medical, or neighborhood factors associated with barriers to neuropsychological evaluations. METHODS: Retrospective chart review identified pediatric patients with a medulloblastoma diagnosed between 2005 and 2024. Demographic, medical, and neighborhood factors were gleaned from the medical records. RESULTS: Of the 67 identified patients, only 36 (53.73%) completed a clinical neuropsychological evaluation. Patients who obtained a neuropsychological evaluation were more likely to be non-Hispanic [X2 (1,62) = 9.20, p = <.01], diagnosed at younger ages [t(60) = - 8.40, p = < 0.001], treated with photon radiation therapy [X2 (1,62) = 15.24, p = < 0.001], live closer to the hospital [t(60) = 3.19, p = 0.001], and live in communities with higher health-related resources [t(60) = - 2.09, p = 0.02]. The two groups did not differ by any of the medical/clinical factors. CONCLUSIONS: Neuropsychological evaluations assess for cognitive changes following cancer directed treatment, clarify other diagnostic possibilities (e.g., learning or attention difficulties), and facilitate access to appropriate accommodations and school- and community- based services. Although neuropsychological evaluations are recommended as standard of care following treatment for medulloblastoma, we identified demographic, medical, and neighborhood-level factors that serve as barriers to clinical neuropsychological evaluations. Implications for clinical care and recommendations to address these barriers are discussed.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Peterson RK, Choi JH, King TZ, et al. Demographic, medical, and neighborhood barriers to clinical neuropsychological services in pediatric medulloblastoma patients treated in the United States. J Neurooncol. 2025. PMID: 39873918. doi:10.1007/s11060-025-04940-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。